Bath & Body Works (NYSE:BBWI) Updates FY26 Earnings Guidance

Bath & Body Works (NYSE:BBWI - Get Free Report) issued an update on its FY26 earnings guidance on Tuesday morning. The company provided EPS guidance of $3.25-360 for the period, compared to the consensus EPS estimate of $3.61. Bath & Body Works also updated its Q1 guidance to $0.36-0.43 EPS.

Bath & Body Works Price Performance

BBWI opened at $30.45 on Tuesday. The firm has a 50 day simple moving average of $37.09 and a 200 day simple moving average of $34.14. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The company has a market cap of $6.60 billion, a price-to-earnings ratio of 7.43, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, beating the consensus estimate of $2.04 by $0.05. The company had revenue of $2.79 billion during the quarter, compared to analysts' expectations of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. As a group, analysts expect that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.63%. The ex-dividend date was Friday, February 21st. Bath & Body Works's payout ratio is 21.98%.

Remove Ads

Bath & Body Works declared that its board has initiated a stock buyback program on Thursday, February 27th that authorizes the company to buyback $500.00 million in shares. This buyback authorization authorizes the company to purchase up to 6.4% of its stock through open market purchases. Stock buyback programs are generally a sign that the company's management believes its shares are undervalued.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on BBWI shares. Argus reiterated a "hold" rating on shares of Bath & Body Works in a research report on Friday, January 10th. Wells Fargo & Company raised shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $42.00 to $48.00 in a research report on Friday, January 10th. Cowen reissued a "buy" rating on shares of Bath & Body Works in a report on Thursday, February 27th. Deutsche Bank Aktiengesellschaft raised their price objective on Bath & Body Works from $51.00 to $52.00 and gave the stock a "buy" rating in a research note on Tuesday, November 26th. Finally, Telsey Advisory Group reaffirmed an "outperform" rating and set a $43.00 price target on shares of Bath & Body Works in a research report on Thursday, February 27th. Five investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $45.06.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.